GE HealthCare secures CE mark for Carevance, advancing scalable, cost-effective monitoring across care settings.

The "UAE Interventional Cardiology Devices Market, By Region, Competition, Forecast and Opportunities, 2020-2030F" report has ...

MINNEAPOLIS, Oct. 6, 2025 /PRNewswire/ -- Acorai, a clinical-stage company pioneering non-invasive hemodynamic monitoring for heart failure management, this week announced topline results from the ...

Built on GE HealthCare’s 50+ years of clinical excellence in patient monitoring, Carevance is an advanced, reliable monitoring solution that leverages proprietary algorithms and proven technologies to ...

Nihon Kohden Corporation (($JP:6849)) announced an update on their ongoing clinical study. The recent clinical study update from Nihon Kohden ...

A new ultrasound-based imaging tech has been developed to map the organ blood flow in four dimensions (3D + time) — a level ...

Cardiac performance in patients with HF can be determined with measurement of the time for peak oxygen uptake to decrease by more than 12.5%.

During his regular checkup, a 9-year-old clouded leopard named Masala undergoes a procedure to get a tiny heart monitor implanted under his skin at the Smithsonian's Conservation Biology Institute in ...

A prospective study conducted at Avicenna University Hospital (Cadi Ayyad University) suggests that the plethysmographic ...

Once limited by bulky, expensive imaging tools, veterinarians now have access to innovative technologies that are ...

The company is enrolling patients in an early feasibility trial as part of plans to launch its device in 2027.